MusclePharm Strengthens Management Team Adding John H. Bluher as COO and EVP
<div class="xn-content"><p><span class="xn-location"><location value="LU/us.co.denver" idsrc="xmltag.org">DENVER</location></span>, <span class="xn-chron"><chron>Sept. 20, 2011</chron></span> /PRNewswire/ -- <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm Corporation</org> (OTCBB: MSLP), an expanding U.S. nutritional supplement company ("<org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org>" or the "Company"), is pleased to announce<b></b><span class="xn-person"><person>John H. Bluher</person></span> has been named Chief Operating Officer and Executive Vice President for <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm Corporation</org> ("MSLP"). In announcing the new appointment, <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org> CEO <span class="xn-person"><person>Brad Pyatt</person></span> said, "As COO, John brings us exceptional depth and balance. His broad range of experience with public companies, boards and financial structuring in addition to mergers and acquisitions will prove helpful as we are positioning <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org> for continued growth and profitability in 2012. He has proven abilities to realize the potential of an organization while rationalizing operational cost. We are extremely excited about how John will contribute to the further strengthening of <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org>'s leadership position and growth prospects." </p><p><person>Mr. Bluher</person> will immediately join the Executive Committee and the MSLP Board of Directors in <span class="xn-chron"><chron>October 2011</chron></span>. As COO, he reports to <person>Mr. Pyatt</person> and has responsibility for functional management and day-to-day operations. His long-range goals are to help with budgeting, managing MSLPs capital structure, structure departments as the company grows, develop control processes, and assist in developing supply chain management and inventory controls. Working closely with <person>Mr. Bluher</person>, <person>Mr. Pyatt</person> will now have time to focus on longer-range strategies, business development, extending the branding and marketing opportunities for <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org>. Finance, Legal, Operations, Investor Relations, Public Relations, and Administration report to <person>Mr. Bluher</person>. Mr. Bluher has been working as a consultant to MSLP for the past three months.</p><p><person>Mr. Bluher</person> said: "I am excited for the opportunity to come into <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org> at such an important time for this young company. The company is growing at a tremendous pace and with the brand recognition accelerating, Brad felt that he needed someone focused full time on the internal controls, budgets, and financial and capital requirements of the company. Brad has aggressively built the brand and grown the company with innovative products, I will be focusing on building on his success so we can provide a return to our equity investors." </p><p><person>Mr. Bluher</person> has significant experience working with corporate structuring, corporate boards and committees, risk management, and public company corporate governance. He has 20 years of experience working in financial services public companies as Chief Legal Officer, <person>General Counsel</person>, Director of Risk, and Chief Compliance Officer. Most recently he was Chief Legal Officer at Neuberger Berman and managed the sale of this company out of the Lehman Brothers estate. He was also <person>General Counsel</person> of the <org>Investment Management Division of Lehman Brothers</org>, Inc. His experience also includes negotiating transactions and purchases, and sales of assets and properties on a global basis. He has deep experience in creating and implementing corporate governance plans, working in the corporate board room, and as director of risk, developing internal audit programs and insurance programs for public companies. </p><p>He has served on the boards of <org>ICI Mutual Insurance Company</org>, the NASDAQ Chairman's <org>Advisory Board</org>, <org>Cherry Hills Founders Group, Inc.</org>, and the <span class="xn-org"><org>University of Wyoming</org></span>, <org>College of Law Advisory Board</org>. <person>Mr. Bluher</person> is currently on the Board of <org value="ACORN:3842740850" idsrc="xmltag.org">Targeted Medical Pharma, Inc.</org>, Safe Communications, Inc. and <span class="xn-org"><org>University of Wyoming</org></span> Foundation Board. </p><p><b>About <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm Corporation</org></b></p><p>Headquartered in <span class="xn-location"><location value="LU/us.co.denver" idsrc="xmltag.org">Denver, Colorado</location></span>, <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm</org> is a healthy life-style company that develops and manufactures a full line of NSF and Informed Choice approved nutritional supplements that are free of banned substances. Based on years of research at the <org>MusclePharm Sports Science Center</org>, the products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the <org>National Football League</org>, Mixed Martial Arts, and <org value="ACORN:1746386108" idsrc="xmltag.org">Major League Baseball</org>. The Company's products address all categories of an active lifestyle, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe, and <org>Vitamin World</org>. MusclePharm products are also sold in over 100 online stores, including <org value="ACORN:3294283312" idsrc="xmltag.org">bodybuilding.com</org>, Amazon.com and Vitacost.com. For more information, please visit <a href="http://www.musclepharm.com/">www.musclepharm.com</a>.</p><p><b>Forward Looking Statements</b></p><p>The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</p><p><b>PR Contact:</b><br /><span class="xn-person"><person>Annette Dallavalle</person></span><br />5W Public Relations<br />(212) 584-4299<br /><a href="mailto:[email protected]">[email protected]</a><br /></p><p>SOURCE <org value="NASDAQ-OTCBB:MSLP" idsrc="xmltag.org">MusclePharm Corporation</org></p></div>


BNY Mellon Depositary Receipts Will Take Part in Pilot Program Using XBRL for Corporate Actions
Advisor News
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
More Advisor NewsAnnuity News
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- SENATE APPROVES BILL TO LIMIT PREMIUM INCREASES, PROTECT ACCESS TO HEALTHCARE
- All about AHCCCS: Navigating Arizona Medicaid’s changing landscape
- GOVERNOR SIGNS BIOMARKER TESTING COVERAGE BILL
- REGULATION OF AI IN PRIOR AUTHORIZATION AND CLAIMS REVIEW: A LOOK AT FEDERAL AND STATE CONSUMER PROTECTIONS
- LEADING HEALTH ORGANIZATIONS URGE NC LAWMAKERS TO RECONSIDER PROPOSAL IMPLEMENTING MEDICAID CUTS
More Health/Employee Benefits NewsLife Insurance News
- 2025 Insurance Abstracts
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
More Life Insurance News